- Waltham, United States
- Hybrid
- US$123,000 – US$205,000 pa
- Lead
Owns operational delivery of diagnostics across early and late-stage oncology trials, from biosample collection and clinical trial assays at reference and central labs to audit-ready data. Works in a matrix with Diagnostic Strategy, Biomarker, Clinical Operations, Data Management, Regulatory, Quality and Procurement, plus external CROs, labs and vendors, and mentors colleagues as a subject matter expert.
CRO